| 5.89 Delayed Data As of Aug 22 |  -0.17 / -2.81%Today’s Change | 4.98 Today|||52-Week Range 37.27 | -67.20% Year-to-Date |
| Previous close | 6.06 |
| Today’s open | 6.06 |
| Day’s range | 5.85 - 6.09 |
| Volume | 2,723,132 |
| Average volume (3 months) | 2,485,357 |
| Market cap | $305.5M |
| Earnings growth (last year) | +3.97% |
| Earnings growth (this year) | -5.34% |
| Earnings growth (next 5 years) | +31.35% |
| Revenue growth (last year) | +71.84% |
| P/E ratio | NM |
| Price/Sales | 9.80 |
| Price/Book | 2.02 |
| Today’s change | Today’s % change | |
|---|---|---|
| XERSXeris Pharmaceutical... | -0.74 | -6.07% |
| PGNXProgenics Pharmaceut... | +0.64 | +16.58% |
| ALBOAlbireo Pharma Inc | -0.38 | -1.44% |
| MIRMMirum Pharmaceutical... | +0.09 | +0.64% |
| Next reporting date | November 11, 2019 |
| EPS forecast (this quarter) | -$1.80 |
| Annual revenue (last year) | $95.4M |
| Annual profit (last year) | -$368.0M |
| Net profit margin | -385.80% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Patrick J. Mahaffy |
Chief Financial & Accounting Officer Daniel W. Muehl |
Corporate headquarters Boulder, Colorado |
